NYSE · Common Stock · Electromedical & Electrotherapeutic Apparatus
30 entities across 15 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-23 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Accellent LLC | Colorado | |
| Aran Biomedical Teoranta | Ireland | |
| Brivant Limited, d/b/a Lake Region Medical | Ireland | |
| Connemara Biomedical Holdings Teo. | Ireland | |
| CPE 1, LLC | Delaware | |
| Greatbatch LLC | Delaware | |
| Greatbatch Ltd., d/b/a Greatbatch Medical | New York | |
| Greatbatch Medical, S. de R.L. de C.V. | Mexico | |
| Greatbatch Medical SA | Switzerland | |
| Greatbatch MCSO, S. de R.L. de C.V | Mexico | |
| Greatbatch Netherlands B.V. | Netherlands | |
| Integer EBDO SA | Switzerland | |
| Integer Hydrophilic Technologies LLC | Delaware | |
| Integer N2 Surface Technologies LLC | Delaware | |
| Integer Precision Technologies, LLC | Delaware | |
| Integer SMI Ltd. | Israel | |
| Lake Region Manufacturing, Inc., d/b/a Lake Region Medical | Minnesota | |
| Lake Region Medical Limited | Ireland | |
| Lake Region Medical, Inc., d/b/a Lake Region Medical | Maryland | |
| Lake Region Medical Holdings Limited | Ireland | |
| Lake Region Medical Sdn. Bhd. | Malaysia | |
| Lake (Shanghai) Medical Device Trading Co., Ltd. | China | |
| Oscor Inc. | Florida | |
| Oscor Caribe LLC | Florida | |
| Oscor Europe GmbH | Germany | |
| Proxy Biomedical Ltd. | Ireland | |
| Pulse Technologies, Inc. | Pennsylvania | |
| Integer VSi Technologies, LLC | Delaware | |
| Venusa de Mexico, S. de R.L. de C.V. | Mexico | |
| Venusa, Ltd | New York |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $1.1B | $77.3M | $134.5M | 26.6% | 33,113,000 |
| FY2021 | $1.2B | $96.8M | $103.2M | 27.6% | 33,258,000 |
| FY2022 | $1.4B | $66.4M | $41.7M | 26.1% | 33,357,000 |
| FY2023 | $1.6B | $90.7M | $60.3M | 26.2% | 33,758,000 |
| FY2024 | $1.7B | $119.9M | $99.8M | 26.7% | 35,649,000 |
| FY2025 | $1.9B | $102.8M | $105.1M | 27.0% | 35,594,000 |
1 institutions tracked — 1 added, 0 reduced.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Index | 879,457 | +45,095 | $82.2M |
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Integer Holdings Corp files under SIC 3845 — all 4 electromedical & electrotherapeutic apparatus companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
